Month: January 2025

The Nomination Committee is a sub-committee of the Board of Directors which shall assist the Board with the process of Board succession planning, identification and nomination of Board candidates, alternate Board candidates as well as members of the Board‘s committees. Eimskip‘s Annual General Meeting will be held on 27 March 2025 and the Nomination Committee is now open for nominations. Declaration of candidacy shall be submitted to the committee on a special form that can be accessed at the Company‘s Investor website under AGM documents, and shall be returned to the email nominationcommittee@eimskip.com Deadline for declaring candidacy to the Nomination Committee passes at 12:00 (GMT) on Friday 14 February 2025. The committee reserves the right to discuss candidacies that are received later. All current members of the Board of Directors...

Earnings Release: Wednesday, February 5, 2025, Before Market OpensConference Call and Webcast: Wednesday, February 5, 2025, at 8:30 a.m. ET MONACO, Jan. 31, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE), announced today that it will release its results for the fourth quarter ended December 31, 2024 before the market opens in New York on February 5, 2025. Conference Call Details: On Wednesday, February 5, 2025 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the financial results. Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US), 0808-238-9064 (from the UK) or +1-412-317-9258 (from outside the US). Please quote “Costamare”. A replay of the conference call will be available until February 12, 2025....

NORWELL, Mass., Jan. 31, 2025 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ: DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the pricing of its public offering of an aggregate of 5,937,100 units at a public offering price of $0.7832 per unit. Each unit consists of one share of Class A common stock (or pre-funded warrant in lieu thereof) and one Class A warrant to purchase one share of Class A common stock. The Class A warrants will have an exercise price of $0.7832 per share, will be exercisable immediately upon...

Geneva, Switzerland, Jan. 31, 2025 (GLOBE NEWSWIRE) — In-person registration: https://www.sealsq.com/quantum-day-invitation  SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that in collaboration with the OISTE.ORG Foundation, is developing the next generation of Post-Quantum Cryptography Root of Trust (“Quantum RootCA”), an advanced cryptographic solution designed to secure digital identities, systems, and communications against the imminent threat posed by quantum computing. The launch of the Quantum RootCA is expected as early as Q1 2025. The Quantum RootCA employs Post-Quantum Cryptography (PQC) algorithms to protect against the vulnerabilities of traditional encryption methods...

WISeKey WISe.Social Network: A New Era of Digital Identity Ownership and Data Privacy WISe.Social provides a model for how social networks can align with privacy regulations while fostering a more ethical digital ecosystem. Geneva, January 31, 2025 –WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces that in an era where personal data has become the currency of the digital world, the Company is setting a new standard with WISe.Social, a proof-of-concept social media platform designed to restore user control over digital identity, data privacy, and consent. Unlike conventional platforms that monetize user information without transparent accountability, WISe.Social is built from the ground up with privacy, security, and user sovereignty as its...

Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Gross Profit Margin of 50.2%, an increase of 140 basis points quarter-over quarter Generated Positive Cashflow from Operations in the quarter Fourth quarter and full year 2024 earnings conference call scheduled for March 6, 2025, at 5 p.m. ET TORONTO, Jan. 31, 2025 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced preliminary and unaudited financial results for its quarter ended December 31, 2024. All amounts are in U.S. dollars. For the fourth quarter of 2024, the Company anticipates:Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024. Gross Profit Margin of 50.2%, up 140 basis points...

Multilingual upgrade will make INBS’ Drug Screening System accessible to over 4 billion users worldwide, including users across the Americas, Europe, Asia and the Middle East, supporting its strategic global expansion goals and planned 2025 entry into the US market. NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced plans for a major upgrade to its Intelligent Fingerprinting Drug Screening System. The system upgrade will support multiple languages spoken across North and South America, Europe, Asia Pacific and the Middle East, making the system accessible to over 4 billion speakers worldwide1. By introducing multilingual capabilities to its portable Drug Screening...